Skip to content
10-Q

Quarterly Report

Journey Medical Corp DERM

0001104659-26-060297

← back to feed
Filed
May 13, 2026 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Diluted Q1 2026 · Mar 31, 2026 27.31M sh
Shares Diluted Q1 2026 · Mar 31, 2025 22.61M sh
Operating Cash Flow Q1 2026 · Mar 31, 2026 $2.91M
Operating Cash Flow Q1 2026 · Mar 31, 2025 −$2.83M
Long Term Debt Q1 2026 · Mar 31, 2026 $22.87M
Long Term Debt Q1 2026 · Dec 31, 2025 $25.28M
Cash And Equivalents Q1 2026 · Mar 31, 2026 $27.22M
Cash And Equivalents Q1 2026 · Dec 31, 2025 $24.09M
Stockholders Equity Q1 2026 · Mar 31, 2026 $30.83M
Stockholders Equity Q1 2026 · Dec 31, 2025 $31.85M
Stockholders Equity Q1 2026 · Mar 31, 2025 $21.54M
Stockholders Equity Q1 2026 · Dec 31, 2024 $20.07M
Current Liabilities Q1 2026 · Mar 31, 2026 $37.83M
Current Liabilities Q1 2026 · Dec 31, 2025 $37.44M
Total Liabilities Q1 2026 · Mar 31, 2026 $60.7M
Total Liabilities Q1 2026 · Dec 31, 2025 $62.74M
Current Assets Q1 2026 · Mar 31, 2026 $64.97M
Current Assets Q1 2026 · Dec 31, 2025 $66.87M
Total Assets Q1 2026 · Mar 31, 2026 $91.53M
Total Assets Q1 2026 · Dec 31, 2025 $94.59M
Eps Diluted Q1 2026 · Mar 31, 2026 −$0.08
Eps Diluted Q1 2026 · Mar 31, 2025 −$0.18
Eps Basic Q1 2026 · Mar 31, 2026 −$0.08
Eps Basic Q1 2026 · Mar 31, 2025 −$0.18
Sga Expense Q1 2026 · Mar 31, 2026 $10.11M
Sga Expense Q1 2026 · Mar 31, 2025 $10.57M
Net Income Q1 2026 · Mar 31, 2026 −$2.23M
Net Income Q1 2026 · Mar 31, 2025 −$4.07M
Operating Income Q1 2026 · Mar 31, 2026 −$1.49M
Operating Income Q1 2026 · Mar 31, 2025 −$3.32M
Cost Of Revenue Q1 2026 · Mar 31, 2026 $6.22M
Cost Of Revenue Q1 2026 · Mar 31, 2025 $4.79M
Revenue Q1 2026 · Mar 31, 2026 $15.92M
Revenue Q1 2026 · Mar 31, 2025 $13.14M
Rd Expense Q1 2026 · Mar 31, 2025 $39K